{"id":58102,"date":"2023-09-25T16:05:40","date_gmt":"2023-09-25T14:05:40","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\/"},"modified":"2023-09-25T16:05:40","modified_gmt":"2023-09-25T14:05:40","slug":"life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\/","title":{"rendered":"Life with a Central Line [WEBINAR]: Key Considerations from the Patient\u2019s Perspective"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>Registration now open: Beyond the vein, see central vascular access through the eyes of the patient<\/i><\/p>\n<p>MISSISSAUGA, Ontario&#8211;(BUSINESS WIRE)&#8211;Covalon Technologies Ltd. (the &#8220;Company&#8221; or &#8220;Covalon&#8221;) (TSXV: COV; OTCQX: CVALF), a leader in advanced medical technologies, proudly announces the opening of registration for a unique, patient-led webinar. The event, scheduled for Wednesday, September 27, 2023, from 1-2 PM EST, is designed to provide attendees with a profound look into the patient\u2019s world \u2013 living with central vascular access devices.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230925181300\/en\/1897800\/5\/covalon_webinar.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230925181300\/en\/1897800\/21\/covalon_webinar.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20230925181300\/en\/1897800\/5\/covalon_webinar.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230925181300\/en\/1897800\/22\/covalon_webinar.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20230925181300\/en\/1767588\/5\/Covalon_News_Release_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230925181300\/en\/1767588\/21\/Covalon_News_Release_Logo.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20230925181300\/en\/1767588\/5\/Covalon_News_Release_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230925181300\/en\/1767588\/22\/Covalon_News_Release_Logo.jpg\"><\/a><\/p>\n<p>\nGuided by the firsthand experiences of Jessika Buehne and Chalice Richert, who are both clinically trained and have navigated the complexities of central vascular access devices, the webinar aims to underscore the necessity of understanding the patient experience and the importance of compassion in device management and patient care.<\/p>\n<p>\n\u201cThe approach Covalon is taking to listen and amplify the voice of patients speaks volumes,\u201d said Jessika Buehne. \u201cIt shows we aren\u2019t forgotten or aren\u2019t just another ID number to a medical product. Knowing hospitals and device companies are listening gives me hope.\u201d Chalice Richert added, \u201cFinding the right device for your line and skin can make all the difference. It is encouraging that Covalon is considering how patient needs can differ, and I\u2019m excited for the opportunity share my experience, in hopes that it helps others living with a central line.\u201d<\/p>\n<p>\nKey takeaways from the webinar titled: \u201cCentral Vascular Access Devices: Key Considerations from the Patient\u2019s Perspective\u201d include:<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nRecognizing the importance of patient-centered device selection<\/li>\n<li>\nSpecial considerations for long-term IV access<\/li>\n<li>\nGuidance for finding the right device for you, your loved one, or patient<\/li>\n<li>\nBest practices for patient-care team engagement<\/li>\n<li>\nIntimate stories, first-hand patient perspectives, and real-life experiences<\/li>\n<li>\nA dynamic opportunity to share, learn, discuss, and interact<\/li>\n<\/ul>\n<p>\n\u200b\u200b\u200b\u200b\u200b<b>Webinar Details:<\/b><\/p>\n<p>\n<b>Title: <\/b>Central Vascular Access Devices: Key Considerations from the Patient\u2019s Perspective<\/p>\n<p>\n<b>Speakers: <\/b>Jessika Buehne and Chalice Richert<\/p>\n<p>\n<b>Date: <\/b>Wednesday, September 27, 2023, 1 \u2013 2 PM EST<\/p>\n<p>\n<b>Registration Link:<\/b> <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2F39785818.hs-sites.com%2Fen%2Fcovalon-webinar-september-2023&amp;esheet=53560467&amp;newsitemid=20230925181300&amp;lan=en-US&amp;anchor=Central+Vascular+Access+Devices&amp;index=1&amp;md5=589f42b76c36865156f7750e20959571\" rel=\"nofollow noopener\" shape=\"rect\">Central Vascular Access Devices<\/a><\/p>\n<p>\n<b>Hashtags: <\/b>#MARSI, #infectionprevention, #compassionatecare<\/p>\n<p>\nChoosing the right medical dressing for a patient can make the difference between pain vs comfort, infection vs healing, skin injury vs skin integrity.<\/p>\n<p>\nCovalon\u2019s soft silicone dressings provide gentle, non-compromisingly effective care:<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3673390-1%26h%3D1150543862%26u%3Dhttps%253A%252F%252Fcovalon.com%252Fproducts%252Fcovaclear-iv%26a%3DCovaClear&amp;esheet=53560467&amp;newsitemid=20230925181300&amp;lan=en-US&amp;anchor=CovaClear&amp;index=2&amp;md5=a662395bf7e6f2315e75b5ce2c654229\" rel=\"nofollow noopener\" shape=\"rect\">CovaClear<\/a><sup>\u00ae<\/sup> IV \u2013 utilizes soft silicone adhesive technology to help protect patients from skin injuries, but does not incorporate antimicrobials, for use with patients who either do not require or cannot tolerate antimicrobials.<\/li>\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3673390-1%26h%3D1371340489%26u%3Dhttps%253A%252F%252Fcovalon.com%252Fproducts%252Fiv-clear%26a%3DIV%2BClear&amp;esheet=53560467&amp;newsitemid=20230925181300&amp;lan=en-US&amp;anchor=IV+Clear&amp;index=3&amp;md5=27e4cd372cf4eac657de83d66d2ba068\" rel=\"nofollow noopener\" shape=\"rect\">IV Clear<\/a><sup>\u00ae<\/sup> &#8211; the world\u2019s only dual-antimicrobial vascular access dressing that offers complete transparency at and around the insertion site for easy daily assessment. It also utilizes soft silicone adhesive technology to minimize skin injuries and preserve skin barrier functions, and incorporates safe amounts of antimicrobials, without sacrificing efficacy, to protect against chemical irritation.<\/li>\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3673390-1%26h%3D2788744574%26u%3Dhttps%253A%252F%252Fcovalon.com%252Fproducts%252Fsurgiclear%26a%3DSurgiClear&amp;esheet=53560467&amp;newsitemid=20230925181300&amp;lan=en-US&amp;anchor=SurgiClear&amp;index=4&amp;md5=9404a19436a97566ee05a7580abc5b5a\" rel=\"nofollow noopener\" shape=\"rect\">SurgiClear<\/a><sup>\u00ae<\/sup> &#8211; the world&#8217;s only dual-antimicrobial clear postoperative dressing that provides full surgical site visibility, allowing for visual site inspection and thus eliminating the need for early and multiple dressing removals.<\/li>\n<\/ul>\n<p>\nFor healthcare providers who are not able to attend the webinar but are interested in learning more about Covalon\u2019s solutions, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.covalon.com%2F&amp;esheet=53560467&amp;newsitemid=20230925181300&amp;lan=en-US&amp;anchor=www.covalon.com&amp;index=5&amp;md5=b49c062137ba0014049f0e3f97f61f16\" rel=\"nofollow noopener\" shape=\"rect\">www.covalon.com<\/a> or follow Covalon on <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fcovalon-technologies-ltd&amp;esheet=53560467&amp;newsitemid=20230925181300&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=6&amp;md5=2d2f51a07b57e6bea4620ddecca0ce09\" rel=\"nofollow noopener\" shape=\"rect\">LinkedIn<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FCovalonTechnologies%2F&amp;esheet=53560467&amp;newsitemid=20230925181300&amp;lan=en-US&amp;anchor=Facebook&amp;index=7&amp;md5=0247c3a804b76c965c580376660e6919\" rel=\"nofollow noopener\" shape=\"rect\">Facebook<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Fcovalon&amp;esheet=53560467&amp;newsitemid=20230925181300&amp;lan=en-US&amp;anchor=Instagram&amp;index=8&amp;md5=f2a8d3133e7e603c68c840bf0fbfc3cc\" rel=\"nofollow noopener\" shape=\"rect\">Instagram<\/a> or <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FCovalon&amp;esheet=53560467&amp;newsitemid=20230925181300&amp;lan=en-US&amp;anchor=Twitter&amp;index=9&amp;md5=7e2057cfb60446605a1a9423cbb8ea03\" rel=\"nofollow noopener\" shape=\"rect\">Twitter<\/a>.<\/p>\n<p>\n<b>About Covalon<\/b><\/p>\n<p>\nCovalon Technologies Ltd. is a patient-driven medical device company, built on the relentless pursuit to help the most vulnerable patients have a better chance at healing. Through a strong portfolio of patented technologies and solutions for advanced wound care, infection prevention, and medical device coatings, we offer innovative, gentler, and more compassionate options for patients to heal with less infections, less pain, and better outcomes. Our solutions are designed for patients and made for care providers. Covalon leverages its patented medical technology platforms and expertise in two ways: (i) by developing products that are sold under Covalon\u2019s name; and (ii) by developing and commercializing medical products for other medical companies under development and license contracts. The Company is listed on the TSX Venture Exchange, having the symbol COV and trades on the OTCQX Market under the symbol CVALF. To learn more about Covalon, visit our website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fna01.safelinks.protection.outlook.com%2F%3Furl%3Dhttp%253A%252F%252Fwww.covalon.com%26data%3D02%257C01%257C%257C6c73d1c9928a41c6e10508d639ab40b8%257C22d66b9c00bf4437bced9f9cdcdfd520%257C0%257C0%257C636759805008133179%26sdata%3DfeexzBWJvxwgFKmgXXX6M4A9%252FFYG%252FRPXav0FKy98cg8%253D%26reserved%3D0&amp;esheet=53560467&amp;newsitemid=20230925181300&amp;lan=en-US&amp;anchor=www.covalon.com&amp;index=10&amp;md5=16afd853c839a847adb6187729139840\" rel=\"nofollow noopener\" shape=\"rect\">www.covalon.com<\/a>.<\/p>\n<p>\n<i>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.<\/i><\/p>\n<p>\n<i>This news release may contain forward-looking statements which reflect the Company&#8217;s current expectations regarding future events. The forward-looking statements are often, but not always, identified by the use of words such as &#8220;seek&#8221;, &#8220;anticipate&#8221;, &#8220;plan, &#8220;estimate&#8221;, &#8220;expect&#8221;, &#8220;intend&#8221;, or variations of such words and phrases or state that certain actions, events, or results \u201cmay\u201d, \u201ccould\u201d, \u201cwould\u201d, \u201cmight\u201d, \u201cwill\u201d or \u201cwill be taken\u201d, \u201coccur\u201d, or \u201cbe achieved\u201d. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts, but instead represent management\u2019s expectations, estimates, and projections regarding future events. Forward-looking statements involve risks and uncertainties, including, but not limited to, the factors described in greater detail in the \u201cRisks and Uncertainties\u201d section of our management\u2019s discussion and analysis of financial condition and results of operations for the year ended September 30, 2022, which is available on the Company\u2019s profile at <\/i><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedar.com&amp;esheet=53560467&amp;newsitemid=20230925181300&amp;lan=en-US&amp;anchor=www.sedar.com&amp;index=11&amp;md5=0ea1b93a119fef13e5546006d037b840\" rel=\"nofollow noopener\" shape=\"rect\"><i>www.sedar.com<\/i><\/a><i>, any of which could cause results, performance, or achievements to differ materially from the results discussed or implied in the forward-looking statements. Investors should not place undue reliance on any forward-looking statements. The forward-looking statements contained in this news release are made as of the date of this news release, and the Company assumes no obligation to update or alter any forward-looking statements, whether as a result of new information, further events, or otherwise, except as required by law.<\/i><\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nTo learn more about Covalon:<\/p>\n<p>\nBrian Pedlar, CEO, Covalon Technologies Ltd.<br \/>\n<br \/>Email: <a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#x74;&#x6f;&#x3a;&#x62;&#112;&#101;&#100;&#108;&#97;&#114;&#64;cova&#x6c;&#x6f;&#x6e;&#x2e;&#x63;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#98;&#112;&#x65;&#x64;&#108;&#97;&#x72;&#x40;&#99;&#111;&#x76;&#x61;&#108;&#111;&#x6e;&#x2e;&#99;&#111;&#x6d;<\/a><br \/>Phone: 905.568.8400 x 233<br \/>\n<br \/>Toll-Free: 1.877.711.6055<br \/>\n<br \/>Website: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fcovalon.com%2F&amp;esheet=53560467&amp;newsitemid=20230925181300&amp;lan=en-US&amp;anchor=https%3A%2F%2Fcovalon.com%2F&amp;index=12&amp;md5=19618a441cb81f011bf6fab3d8c4e9be\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/covalon.com\/<\/a><br \/>Twitter: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FCovalon&amp;esheet=53560467&amp;newsitemid=20230925181300&amp;lan=en-US&amp;anchor=%40covalon&amp;index=13&amp;md5=da26a7f49abf6f9220c2106589dbdc4c\" rel=\"nofollow noopener\" shape=\"rect\">@covalon<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Registration now open: Beyond the vein, see central vascular access through the eyes of the patient MISSISSAUGA, Ontario&#8211;(BUSINESS WIRE)&#8211;Covalon Technologies Ltd. (the &#8220;Company&#8221; or &#8220;Covalon&#8221;) (TSXV: COV; OTCQX: CVALF), a leader in advanced medical technologies, proudly announces the opening of registration for a unique, patient-led webinar. The event, scheduled for Wednesday, September 27, 2023, from &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-58102","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Life with a Central Line [WEBINAR]: Key Considerations from the Patient\u2019s Perspective - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Life with a Central Line [WEBINAR]: Key Considerations from the Patient\u2019s Perspective - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Registration now open: Beyond the vein, see central vascular access through the eyes of the patient MISSISSAUGA, Ontario&#8211;(BUSINESS WIRE)&#8211;Covalon Technologies Ltd. (the &#8220;Company&#8221; or &#8220;Covalon&#8221;) (TSXV: COV; OTCQX: CVALF), a leader in advanced medical technologies, proudly announces the opening of registration for a unique, patient-led webinar. The event, scheduled for Wednesday, September 27, 2023, from ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-25T14:05:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230925181300\/en\/1897800\/21\/covalon_webinar.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Life with a Central Line [WEBINAR]: Key Considerations from the Patient\u2019s Perspective\",\"datePublished\":\"2023-09-25T14:05:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\\\/\"},\"wordCount\":975,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230925181300\\\/en\\\/1897800\\\/21\\\/covalon_webinar.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\\\/\",\"name\":\"Life with a Central Line [WEBINAR]: Key Considerations from the Patient\u2019s Perspective - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230925181300\\\/en\\\/1897800\\\/21\\\/covalon_webinar.jpg\",\"datePublished\":\"2023-09-25T14:05:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230925181300\\\/en\\\/1897800\\\/21\\\/covalon_webinar.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230925181300\\\/en\\\/1897800\\\/21\\\/covalon_webinar.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Life with a Central Line [WEBINAR]: Key Considerations from the Patient\u2019s Perspective\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Life with a Central Line [WEBINAR]: Key Considerations from the Patient\u2019s Perspective - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\/","og_locale":"en_US","og_type":"article","og_title":"Life with a Central Line [WEBINAR]: Key Considerations from the Patient\u2019s Perspective - Pharma Trend","og_description":"Registration now open: Beyond the vein, see central vascular access through the eyes of the patient MISSISSAUGA, Ontario&#8211;(BUSINESS WIRE)&#8211;Covalon Technologies Ltd. (the &#8220;Company&#8221; or &#8220;Covalon&#8221;) (TSXV: COV; OTCQX: CVALF), a leader in advanced medical technologies, proudly announces the opening of registration for a unique, patient-led webinar. The event, scheduled for Wednesday, September 27, 2023, from ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\/","og_site_name":"Pharma Trend","article_published_time":"2023-09-25T14:05:40+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230925181300\/en\/1897800\/21\/covalon_webinar.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Life with a Central Line [WEBINAR]: Key Considerations from the Patient\u2019s Perspective","datePublished":"2023-09-25T14:05:40+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\/"},"wordCount":975,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230925181300\/en\/1897800\/21\/covalon_webinar.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\/","url":"https:\/\/pharma-trend.com\/en\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\/","name":"Life with a Central Line [WEBINAR]: Key Considerations from the Patient\u2019s Perspective - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230925181300\/en\/1897800\/21\/covalon_webinar.jpg","datePublished":"2023-09-25T14:05:40+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230925181300\/en\/1897800\/21\/covalon_webinar.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230925181300\/en\/1897800\/21\/covalon_webinar.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/life-with-a-central-line-webinar-key-considerations-from-the-patients-perspective\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Life with a Central Line [WEBINAR]: Key Considerations from the Patient\u2019s Perspective"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58102","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=58102"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58102\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=58102"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=58102"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=58102"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}